Metastatic Colorectal Cancer Clinical Trials in Beijing
3 recruitingBeijing, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
Metastatic Colorectal Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.54 enrolled2 locationsNCT07314294
Recruiting
Phase 2
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Metastatic Colorectal Cancer
AstraZeneca120 enrolled76 locationsNCT06792695
Recruiting
Phase 1Phase 2
Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients
Metastatic Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences70 enrolled1 locationNCT06202001